Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer’s disease
Personalized closed-loop neuromodulation therapy resulted in a rapid and sustained improvement in depression
Patterns of pre-treatment reward task brain activation predict individual antidepressant response
More News Items
Mailing Address:
